Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol - sprookjes - yvandenbroek - TriplyDB

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

http://www.wikidata.org/entity/Q28476811

about

Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever New small-molecule drug design strategies for fighting resistant influenza A The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses Investigational hemagglutinin-targeted influenza virus inhibitors.Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.Emerging antiviral strategies to interfere with influenza virus entry.Hantavirus infections for the clinician: from case presentation to diagnosis and treatment.Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking.The influenza fusion peptide adopts a flexible flat V conformation in membranes.Development of novel entry inhibitors targeting emerging viruses.Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans.Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.Lipids in innate antiviral defense.Antiviral strategies against influenza virus: towards new therapeutic approaches.Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions.5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses The Location of the Protonated and Unprotonated Forms of Arbidol in the Membrane: A Molecular Dynamics Study.Antiviral Strategies Against Chikungunya Virus.The influenza fusion peptide promotes lipid polar head intrusion through hydrogen bonding with phosphates and N-terminal membrane insertion depth.Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.The Antiviral Drug Arbidol Inhibits Zika Virus.

P2860

Q27457152-075AB2A6-6A0E-4FAC-A62B-2DB30FF2E806 Q28080554-8D1F98BD-F17D-4D4D-B08F-830184D15FAB Q28271798-E8CDC36A-7319-42D0-B5FC-6CB758802DAB Q30240175-18C1FF97-4AF3-4556-B67A-41C28F177DE1 Q30431968-B8A646B3-C025-4E4D-B025-44E7230F3A13 Q30432421-A5E9EC61-77D6-4857-9981-DBCEB6BF0327 Q33401056-413DCB58-2B5A-4A0E-9237-C3CACB42FF24 Q34636137-BB1966F4-1FC5-49D1-99DE-DB5E64609272 Q34652154-25FC2BEE-E5A1-40C1-96A0-151F4E159B68 Q35962567-76F1FB03-FAB9-4D60-8B4F-7BCA0405A284 Q36655280-41F74A59-E313-4133-98E4-BFCDAFCA9A58 Q36757686-BBE48B01-D4BD-42B7-95F3-A718913E3CD7 Q37991389-DB23E626-7CD9-481B-80DB-8E9CFDBE2F28 Q38151881-994F2F24-17B7-4F50-B444-B9146BA9981A Q38153910-A9841D34-5BBA-4FB8-8688-7969B0058C09 Q38202012-1BEF9B68-365A-41DB-B890-5A6233564D3A Q39452637-42595B67-A0A4-475D-B108-D90CE6B305E3 Q39788993-B09B7900-B002-4738-8A82-BF84894296AF Q40026277-4CE201A2-E01E-4B8E-BD38-C565F98D4F75 Q40656579-8A6795BF-FC0F-44CA-9859-48C2B7B239D9 Q42229093-6622B236-8C12-4A87-9AFD-2F11A016BAC9 Q45323703-93A45017-B494-4712-80B4-6031AADA05C6 Q55084371-94F425FD-6130-4007-9A09-FE22998E2885

P2860

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

http://www.wikidata.org/entity/Q28476811

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@ast

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@en

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@nl

type

label

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@ast

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@en

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@nl

prefLabel

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@ast

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@en

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@nl

P1433

Q28476811-F8A0C408-DD66-4B63-B249-ECE68F9404BD

P1476

Q28476811-EFB04B12-A97C-43B0-9AD5-CF1ED829F858

P2093

Q28476811-2EDB9C3B-4204-4AAC-B847-C8B7909367FB

Q28476811-51CC1B50-6598-4926-B1FA-6BD2283B1929

Q28476811-577785F1-3E2C-4800-9F93-3144BCF55B2D

Q28476811-71A499ED-9E62-451B-ADCE-6CD4F98A771F

Q28476811-CDC2BFE2-CCAC-40D3-8778-8C0EA8A8A924

Q28476811-D382F9F4-983B-4C54-9491-1D576D8C90DB

P2860

Q28476811-00664EA0-D283-40A3-80F1-A8A85918F78C

Q28476811-04C81DA1-B321-470C-9ACD-5348CCE35159

Q28476811-09BE306E-6100-4962-8CB3-95B911689685

Q28476811-0E625832-E7A0-44C8-92E8-041BDD29F5DC

Q28476811-0F62AC6F-9D86-4EE0-89C7-750F9C7318A7

Q28476811-0FD88034-12D7-4CC6-87C8-8944BD8C2168

Q28476811-1C45690C-631A-49EB-A094-530FE18916D4

Q28476811-226F5A65-260F-4EF5-9F55-8B10BD4B4D03

Q28476811-22973E5E-57C2-40F5-9042-CF84503DB27D

Q28476811-27A37A64-8E7E-4698-9946-06E259656282

P304

Q28476811-D7850DA2-88E3-4AE7-B79F-05A5C66C8E1A

P31

Q28476811-B22FB959-3678-4B2C-BCFA-C39BB0B6A636

P356

Q28476811-FD76B96B-99FE-4287-877B-3AB91F817B15

P407

Q28476811-5649EA46-6C91-4DE5-BC32-0681173FDC55

P433

Q28476811-7D1479E0-CFEF-4BE3-A2DD-5275CAC442E6

P478

Q28476811-24EC7F81-C11E-4700-9EED-6F866AE209AA

P50

Q28476811-25412679-9C42-4066-8290-FC1E3678950D

Q28476811-39762CC0-2788-4105-A823-CE82316F69A6

Q28476811-4FF53CB5-1D44-411A-9E63-09A67F2FE601

Q28476811-AC72887B-2258-4413-ABDC-9047F2A7B277

Q28476811-B2A965B5-14C6-4A44-888F-33874CD3DBF5

P577

Q28476811-CC163A9F-1906-4763-B0E5-6CDAA6A5B955

P5875

Q28476811-AC77C048-0203-4B5B-888D-E7E7A10739E1

P698

Q28476811-04C2650D-D988-40DE-AD62-EF3B0E214226

P921

Q28476811-086A0A64-E9B5-4FFF-B390-8785507420B8

P932

Q28476811-41C64F67-0155-498B-A725-12BB02838DBA

P356

JOURNAL.PONE.0015874

P1433

P1476

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

@en

P2093

Anja Böckmann

http://www.w3.org/2001/XMLSchema#string

Elodie Teissier

http://www.w3.org/2001/XMLSchema#string

Eve-Isabelle Pécheur

http://www.w3.org/2001/XMLSchema#string

François Penin

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Lavergne

http://www.w3.org/2001/XMLSchema#string

Roland Montserret

http://www.w3.org/2001/XMLSchema#string

P2860

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection

Identification of hepatoprotective flavonolignans from silymarin

Viral and developmental cell fusion mechanisms: conservation and divergence

Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay.

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex.

The pH sensor for flavivirus membrane fusion

P304

e15874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0015874

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

François-Loïc Cosset

Dimitri Lavillette

Giorgia Zandomeneghi

P577

2011-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49800576

http://www.w3.org/2001/XMLSchema#string

P698

21283579

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

P932

3026800

http://www.w3.org/2001/XMLSchema#string